Safety, immunogenicity, and clinical response of a survivin-based peptide vaccine in therapy-resistant advanced cancer: Results from a phase I/II trial

被引:6
作者
Becker, J. C.
Wobser, M.
Hofmeister, V.
Bauer, B.
Broecker, E. B.
Straten, P. Thor
Andersen, M. H.
机构
[1] Univ Wurzburg, Wurzburg, Germany
[2] Herlev Univ, Herlev, Denmark
关键词
D O I
10.1200/jco.2008.26.15_suppl.3046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3046
引用
收藏
页数:1
相关论文
empty
未找到相关数据